Zittoun R, Garand R, Zittoun J, Pillon-Hardy M E, Cadiou M, Bilski-Pasquier G
Ann Med Interne (Paris). 1979;130(2):59-64.
The diagnostic and prognostic value of the assay of lysozyme in serum and urine was appreciated in 184 cases of acute leukemia. The levels were decreased in the lymphoblastic, mainly of the non B-non T type, and undifferenciated varieties, markedly raised in the monoblastic and myelo-monocytic varieties, while in the myeloblastic ones they were found normal, decreased or slightly increased, and, on the average, significantly higher in the well differenciated than in the poorly differenciated types. For a given cytological type, the level of lysozyme is not correlated with the frequency of the induction of complete remission. However, in the acute myeloblastic leukemia, a significantly higher frequency of infection during or after the induction treatment was observed in the cases presenting initially without a raised serum lysozyme level.
对184例急性白血病患者血清和尿液中溶菌酶检测的诊断和预后价值进行了评估。在淋巴细胞性白血病(主要是非B非T型和未分化型)中溶菌酶水平降低,在单核细胞性和粒-单核细胞性白血病中显著升高,而在粒细胞性白血病中,溶菌酶水平正常、降低或略有升高,并且平均而言,分化良好型白血病的溶菌酶水平显著高于分化不良型。对于给定的细胞类型,溶菌酶水平与完全缓解诱导频率无关。然而,在急性粒细胞性白血病中,最初血清溶菌酶水平未升高的患者在诱导治疗期间或之后发生感染的频率显著更高。